Press Release: TherOx : ZOLL Therox Receives CE Mark Approval for Supersaturated Oxygen Therapy

May 4, 2020 - CHELMSFORD, MASS. - ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today it has received CE Mark approval to market and distribute its SuperSaturated Oxygen (SSO2) Therapy System in Europe. SSO2 Therapy provides interventional cardiologists with the first and only clinically proven treatment beyond percutaneous coronary intervention (PCI) to significantly reduce muscle damage in heart attack patients.1read more